moneymaker_BX schreef op 22 december 2020 22:26:
urce: Lineage)
Nonetheless, if Ruconest is effective, it may only become an approved COVID-19 treatment sometime in the coming months. With vaccines supposedly ready to be distributed, it seemed plausible that this approval would be too late for widespread use in hospitals. Fortunately for Pharming and unfortunately to the world, in my previous article I noted:
'Scientists continue to be worried about COVID-19 mutations. It is possible that a new mutation emerges that causes vaccines to be ineffective. Since Ruconest is treating the symptoms of a COVID-19 infection, I deem it as plausible that Ruconest continues to be effective if a mutation emerges, if it is currently effective obviously. Pharming Group provides a unique opportunity to hedge that vaccine risk in one's portfolio. '